NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/22/2025
Back to search
Official data from USPTO
STEMCYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000088064917Class
39, 40, 42, 44
Filing
88064917
Registration
5882064
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
02/22/2025
Trademark type
Combined
Nice classes
39, 40, 42, 44
Filing date
08/03/2018
Registration date
10/15/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/22/2025
Last transaction
02/22/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2017-01-00
First use in commerce
2017-01-00
Drawing code
3
Owner type
03
Owner location
Baldwin Park, CA
Examiner
OPUTA, CHIOMA
Current location
Historical data usage
Mark description
The mark consists of the stylized word "STEMCYTE" above a horizontal line and to the right of a baby and heart design.
Holders and representatives
Holders
StemCyte, Inc.
Representatives
John K. Burke VEDDER PRICE P.C.
Technical classification
Nice Classes
Class 39Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Biomedical servicesstorage of human tissuebloodblood components and stem cells
Class 40
Biomedical servicesumbilical cord blood processing for transplant
Class 42
Biomedical servicesanalysis of human tissuebloodblood components and stem cells for scientific research purposes; medical reference laboratory services and clinical laboratory services for others featuring the testingscreening and analysis of biological substanceshuman leukocyte antigen DNA and serological typing and blood typing; scientific research consulting in the field of biomedicinepathologylaboratory medicine; providing scientific research advice in relation to medical science
Class 44
Biomedical servicesthe collectionmedical screeningmedical testingmedical typing of human tissuebloodblood components and stem cells for diagnostic or treatment purposes; providing medical consulting services in the field of biomedicinepathology and laboratory medicine; providing medical advice in the field of medical care; diagnosis of disease based on professional interpretation of pathology and laboratory medicine results
Publications
History of USPTO decisions and trademark events.
22 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/22/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/21/2025
E815
TEAS SECTION 8 & 15 RECEIVED
10/16/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/15/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/15/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/30/2019
PUBO
PUBLISHED FOR OPPOSITION
07/30/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/10/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/26/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/25/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2019
ALIE
ASSIGNED TO LIE
06/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/18/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/18/2018
GNRT
NON-FINAL ACTION E-MAILED
12/18/2018
CNRT
NON-FINAL ACTION WRITTEN
12/18/2018
DOCK
ASSIGNED TO EXAMINER
11/21/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2018
NWAP
NEW APPLICATION ENTERED
08/07/2018
Continuous trademark protection
Get notified about every new filing that threatens STEMCYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.